» Articles » PMID: 35912343

A Multiscale Study of Phosphorylcholine Driven Cellular Phenotypic Targeting

Overview
Journal ACS Cent Sci
Specialty Chemistry
Date 2022 Aug 1
PMID 35912343
Authors
Affiliations
Soon will be listed here.
Abstract

Phenotypic targeting requires the ability of the drug delivery system to discriminate over cell populations expressing a particular receptor combination. Such selectivity control can be achieved using multiplexed-multivalent carriers often decorated with multiple ligands. Here, we demonstrate that the promiscuity of a single ligand can be leveraged to create multiplexed-multivalent carriers achieving phenotypic targeting. We show how the cellular uptake of poly(2-(methacryloyloxy)ethyl phosphorylcholine)-poly(2-(diisopropylamino)ethyl methacry-late) (PMPC-PDPA) polymersomes varies depending on the receptor expression among different cells. We investigate the PMPC-PDPA polymersome insertion at the single chain/receptor level using all-atom molecular modeling. We propose a theoretical statistical mechanics-based model for polymersome-cell association that explicitly considers the interaction of the polymersome with the cell glycocalyx shedding light on its effect on the polymersome binding. We validate our model experimentally and show that the binding energy is a nonlinear function, allowing us to tune the interaction by varying the radius and degree of polymerization. Finally, we show that PMPC-PDPA polymersomes can be used to target monocytes in vivo due to their promiscuous interaction with SRB1, CD36, and CD81.

Citing Articles

Endothelial cellular senescence and tau accumulation: An interplay full of opportunities?.

Oliveri D, Moschetti G, Griego A, Scarpa E Ibrain. 2024; 10(2):225-230.

PMID: 38915948 PMC: 11193862. DOI: 10.1002/ibra.12154.


The multivalency game ruling the biology of immunity.

Aiassa L, Battaglia G, Rizzello L Biophys Rev (Melville). 2024; 4(4):041306.

PMID: 38505426 PMC: 10914136. DOI: 10.1063/5.0166165.


Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications.

Fonseca M, Jarak I, Victor F, Domingues C, Veiga F, Figueiras A Materials (Basel). 2024; 17(2).

PMID: 38255485 PMC: 10817611. DOI: 10.3390/ma17020319.

References
1.
Lee J, Patel D, Stahle J, Park S, Kern N, Kim S . CHARMM-GUI Membrane Builder for Complex Biological Membrane Simulations with Glycolipids and Lipoglycans. J Chem Theory Comput. 2018; 15(1):775-786. DOI: 10.1021/acs.jctc.8b01066. View

2.
Moghimi S, Kissel T . Particulate nanomedicines. Adv Drug Deliv Rev. 2006; 58(14):1451-5. DOI: 10.1016/j.addr.2006.09.010. View

3.
Fenaroli F, Robertson J, Scarpa E, Gouveia V, Di Guglielmo C, De Pace C . Polymersomes Eradicating Intracellular Bacteria. ACS Nano. 2020; 14(7):8287-8298. DOI: 10.1021/acsnano.0c01870. View

4.
Boullier A, Gillotte K, Horkko S, Green S, Friedman P, Dennis E . The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem. 2000; 275(13):9163-9. DOI: 10.1074/jbc.275.13.9163. View

5.
Colley H, Hearnden V, Avila-Olias M, Cecchin D, Canton I, Madsen J . Polymersome-mediated delivery of combination anticancer therapy to head and neck cancer cells: 2D and 3D in vitro evaluation. Mol Pharm. 2014; 11(4):1176-88. DOI: 10.1021/mp400610b. View